Warfarin Oral Anticoagulant for Atrial Fibrillation and VTE

What Warfarin Is and How It Works

Warfarin is an oral anticoagulant used to prevent and treat blood clots. It is a vitamin K antagonist that reduces the liver’s ability to make vitamin K–dependent clotting factors (II, VII, IX, and X). This slows clot formation and lowers the risk of stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE). Many people also compare warfarin price along with dose and monitoring needs when choosing therapy.

Common uses include nonvalvular and valvular atrial fibrillation, treatment and secondary prevention of DVT/PE, and prevention of thromboembolism in patients with mechanical heart valves. Some post–myocardial infarction patients and certain cardiomyopathy cases may also receive warfarin when clot risk is high.

CanadianInsulin is a prescription referral service. Prescriptions are verified with your clinic, and orders are filled by licensed Canadian pharmacies. We work with vetted partner pharmacies to supply authentic medications, a broad selection, and value‑focused pricing.

Warfarin is taken by mouth, usually once daily. Its effect is monitored using the international normalized ratio (INR). Most indications target an INR of 2.0–3.0. Mechanical mitral valves or certain high‑risk settings may target 2.5–3.5. Dose is individualized and adjusted based on INR, diet, and interacting medications.

Dosage and Usage

• Initiation: Many adults start at 5 mg once daily. Lower starting doses (e.g., 2–3 mg) are often used in older adults, low body weight, liver disease, heart failure, malnutrition, or high bleeding risk.
• Titration: Check INR within a few days of initiation and adjust dose gradually. Recheck frequently until stable, then typically every 4–12 weeks.
• Bridging: In acute DVT/PE or very high‑risk scenarios, parenteral anticoagulation (e.g., heparin/LMWH) is often overlapped with warfarin for at least 5 days and until INR is in range for at least 24 hours.
• Dosing time: Take at the same time daily to support consistent INR control.
• Diet: Keep vitamin K intake consistent. Large changes in leafy greens or vitamin K–containing foods can shift INR.
• Missed dose: If remembered the same day, take as soon as possible. If not, skip and resume the next day. Do not double doses. Record the missed dose and inform the care team if needed.
• Drug and supplement interactions: Many antibiotics, antifungals, amiodarone, antiarrhythmics, and thyroid hormones (e.g., levothyroxine) can change INR. Herbal products and supplements such as St. John’s wort, ginkgo, CoQ10, and saw palmetto may also interact. Alcohol intake can affect INR.
• Procedures: Before surgeries or dental work, clinicians may adjust, hold, or bridge therapy depending on clot and bleeding risk.

• Storage: Store tablets at 20–25°C (68–77°F) in a dry place, away from light and moisture.
• Original container: Keep in the original, tightly closed bottle with the label intact.
• Safety: Keep out of reach of children and pets.
• Travel: Carry medication in your hand luggage with your prescription. Avoid excessive heat. Pack an extra supply and a copy of dosing instructions.
• Expiry: Do not use after the expiration date. Dispose of unused tablets according to local guidance.

Benefits and Savings

Warfarin has long clinical experience, broad indications, and well‑established reversal strategies. It allows precise dose adjustments guided by INR and is suitable for patients with mechanical heart valves, where many newer anticoagulants are not indicated. Once‑daily dosing and wide tablet strength availability support individualized therapy.

Many customers save 60–80% vs typical U.S. prices. See our warfarin coupons page for current offers, if available.

Side Effects and Safety

• Common: easy bruising, nosebleeds, bleeding gums, prolonged bleeding from cuts, heavier menstrual bleeding.
• Gastrointestinal: nausea, stomach upset, abdominal discomfort, diarrhea.
• Dermatologic: rash, mild hair thinning.
• Less common but serious: major bleeding (gastrointestinal or intracranial), hematuria, severe headache, dizziness, weakness.
• Rare: warfarin‑induced skin necrosis (painful skin lesions), purple toe syndrome.

Serious bleeding risk is dose‑related and increases with high INR, older age, falls, renal or hepatic impairment, and use of antiplatelets or NSAIDs. Warfarin is contraindicated in pregnancy due to fetal risk; alternatives are preferred. Vitamin K reverses warfarin effect; prothrombin complex concentrates or fresh frozen plasma may be used in emergencies. Discuss any new medicines, supplements, or diet changes with the care team.

Onset Time

Anticoagulant effect begins within 24–72 hours as existing clotting factors wane. The full therapeutic effect typically appears after 5–7 days. For acute DVT/PE, parenteral anticoagulation is often overlapped until INR remains in range for at least 24 hours. INR changes after starting, stopping, or adjusting interacting medications or diet usually appear within 2–7 days.

Compare With Alternatives

Direct oral anticoagulants (DOACs) are options for many indications. Eliquis® (apixaban) is a factor Xa inhibitor with fixed dosing and no routine monitoring for most patients. It is widely used for nonvalvular atrial fibrillation and VTE treatment. See Eliquis for details.

Xarelto® (rivaroxaban) is another factor Xa inhibitor with once‑daily maintenance dosing for many uses. Food requirements apply to some doses. Monitoring is not routine, but kidney function should be considered. Learn more at Xarelto.

Pradaxa® (dabigatran) is a direct thrombin inhibitor available as capsules. It may be preferred or avoided based on renal function and clinical context. Unlike DOACs, warfarin remains preferred for mechanical heart valves and in some severe kidney disease settings. Choice depends on indication, bleeding risk, comorbidities, interactions, adherence, and cost.

Combination Therapy

• Initial VTE management often uses heparin or low‑molecular‑weight heparin overlapping with warfarin until INR is therapeutic.
• Low‑dose aspirin plus warfarin may be used in select mechanical valve patients per specialist guidance.
• Dual or triple antithrombotic therapy (e.g., with clopidogrel) increases bleeding risk; durations are kept as short as possible.
• When interacting drugs are started or stopped (e.g., amiodarone, antibiotics, levothyroxine), INR checks and dose adjustments may be needed.

Patient Suitability and Cost‑Saving Tips

Warfarin may suit patients requiring precise INR‑guided dosing, mechanical heart valve anticoagulation, or those with conditions where DOACs are less suitable. It can be a good option for patients who can attend regular INR monitoring and maintain stable dietary habits.

Warfarin is generally not suitable during pregnancy. It may be inappropriate after recent major surgery, with active bleeding, severe uncontrolled hypertension, or in patients with poor adherence or significant alcohol misuse. Liver disease, high fall risk, or a history of bleeding require careful risk‑benefit evaluation and closer monitoring.

Cost‑saving ideas include selecting suitable tablet strengths to match the maintenance dose, requesting multi‑month quantities when appropriate, and coordinating refills around clinic INR visits. Stable vitamin K intake may reduce frequent dose changes and extra visits. Consider reminders for reordering so doses are not missed.

Authoritative Sources

FDA Prescribing Information for Coumadin (warfarin)

Health Canada Drug Product Database: Warfarin entries

Manufacturer information for Coumadin (brand warfarin)

Order Warfarin from CanadianInsulin: add to cart, upload your prescription, and we ship with prompt, express, cold‑chain handling.

This page is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare professional for diagnosis and treatment decisions tailored to individual needs.